Lv1
22 积分 2022-10-14 加入
Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease
6个月前
已完结
Long‐term clinical outcomes in steatotic liver disease and incidence of liver‐related events, cardiovascular events and all‐cause mortality
6个月前
已完结
Colorectal cancer incidence in steatotic liver disease (MASLD, MetALD, and ALD)
6个月前
已完结
Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the community
6个月前
已完结
Hepatocyte‐derived MASP1‐enriched small extracellular vesicles activate HSCs to promote liver fibrosis
6个月前
已完结
β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling
6个月前
已完结
Macrophages harness hepatocyte glutamate to boost liver regeneration
7个月前
已完结
Metabolic reprograming of immune cells in MASH
7个月前
已完结
Targeting the ER stress sensor IRE1 protects the liver from fibrosis through the downregulation of the proteostasis factor P4HB/PDIA1
7个月前
已完结
Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH)
7个月前
已完结
皖公网安备34019202002308
